Aharon Schwartz
CIK 1625184 · last filed 2025-09-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$648.9K
Companies
2
Total Filings
12
Lifetime Open-Market Net
$954.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLX | Director | 310,500 | $2.09 | $648.9K | $517.0K | 7 | 2025-09-04 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Director | 50,000 | — | — | $437.8K | 4 | 2020-03-03 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-06 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Buy (P) | +112,200 | $437.8K | EDGAR |
| 2018-05-10 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.